AIDS Healthcare Foundation (AHF) members are staging a weeklong, twice-daily series of protests at drug maker Gilead Science’s Northern California headquarters to protest the company’s policy to impose conditions on 340B providers that use contract pharmacies to dispense 340B-priced drugs. They are also upset about Gilead’s change in its patient assistance program for some HIV medications.
In May, Gilead began requiring hospital and grantee covered entities to provide claims level data for the Bay Area company’s branded hepatitis C products to continue to be eligible for bill to/ship to orders for multiple contract pharmacies. Entities that decline to provide their data and that do not have an in-house pharmacy can select a single contract pharmacy location. The policy does not apply to entities’ wholly owned contract pharmacies.
AIDS Healthcare Foundation (AHF) members are staging a weeklong, twice-daily series of protests at drug maker Gilead Science’s Northern California headquarters to protest the company’s policy to impose conditions on 340B providers that use contract pharmacies to dispense 340B-priced drugs.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.